ALZN
Alzamend Neuro, Inc.Company with tickers: ALZN
CIK
1677077
CUSIP
02262M605
Shares Outstanding
3,804,741
13F Activity (30d)
9 filings
8 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2021-06-22 | 2021-06-17 | |
| 8-K | 2021-07-23 | — | |
| 8-K | 2021-07-28 | — | |
| 10-K | 2021-07-29 | 2021-04-30 | |
| 8-K | 2021-08-04 | — | |
| 8-K | 2021-08-17 | — | |
| 10-Q | 2021-09-13 | 2021-07-31 | |
| 8-K | 2021-09-30 | — | |
| 10-Q | 2021-12-13 | 2021-10-31 | |
| 8-K | 2021-12-17 | — | |
| 10-Q | 2022-03-15 | 2022-01-31 | |
| 8-K | 2022-04-18 | — | |
| 8-K/A | 2022-04-20 | — | |
| 8-K | 2022-06-06 | — | |
| 8-K | 2022-06-28 | — | |
| 8-K | 2022-07-18 | — | |
| 10-K | 2022-07-19 | 2022-04-30 | |
| 8-K | 2022-08-05 | — | |
| 8-K | 2022-08-15 | — | |
| 10-Q | 2022-09-13 | 2022-07-31 | |
| 8-K | 2022-09-22 | — | |
| 8-K | 2022-09-29 | — | |
| 8-K | 2022-10-05 | — | |
| 8-K | 2022-10-31 | — | |
| 8-K | 2022-11-16 | — | |
| 10-Q | 2022-12-12 | 2022-10-31 | |
| 8-K | 2023-01-20 | — | |
| 8-K | 2023-02-03 | — | |
| 10-Q | 2023-03-15 | 2023-01-31 | |
| 8-K | 2023-03-16 | — | |
| 8-K | 2023-03-22 | — | |
| 8-K | 2023-04-03 | — | |
| 8-K | 2023-04-25 | — | |
| 8-K | 2023-04-26 | — | |
| 8-K | 2023-06-22 | — | |
| 10-K | 2023-07-27 | 2023-04-30 | |
| 8-K | 2023-08-07 | — | |
| 8-K | 2023-08-16 | — | |
| 8-K | 2023-09-08 | — | |
| 10-Q | 2023-09-13 | 2023-07-31 | |
| 8-K | 2023-09-22 | — | |
| 8-K | 2023-09-29 | — | |
| 8-K | 2023-10-30 | — | |
| 8-K | 2023-11-16 | — | |
| 10-Q | 2023-12-15 | 2023-10-31 | |
| 8-K | 2024-01-05 | — | |
| 8-K | 2024-02-02 | — | |
| 8-K | 2024-03-07 | — | |
| 8-K | 2024-03-22 | — | |
| 10-Q | 2024-03-25 | 2024-01-31 |
Showing 1–50 of 87 filings